Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry

OBJECTIVE: Cholinesterase inhibitors (ChEIs) and memantine are the only approved pharmacological treatments for Alzheimer’s disease (AD). Recent literature suggests reductions in cardiovascular burden and risk of stroke in ChEI users. However, the clinical effectiveness of these drugs in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Secnik, Juraj, Schwertner, Emilia, Alvarsson, Michael, Hammar, Niklas, Fastbom, Johan, Winblad, Bengt, Garcia-Ptacek, Sara, Religa, Dorota, Eriksdotter, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Care/Education/Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039592/
https://www.ncbi.nlm.nih.gov/pubmed/31958305
http://dx.doi.org/10.1136/bmjdrc-2019-000833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039592/
https://www.ncbi.nlm.nih.gov/pubmed/31958305
http://dx.doi.org/10.1136/bmjdrc-2019-000833

Ejemplares similares